Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$314.68 - $395.94 $629 - $791
-2 Reduced 0.32%
619 $203,000
Q1 2024

May 01, 2024

BUY
$338.27 - $413.0 $210,065 - $256,473
621 New
621 $245,000
Q3 2023

Nov 06, 2023

BUY
$354.9 - $412.41 $195,549 - $227,237
551 New
551 $206,000
Q1 2023

May 05, 2023

BUY
$232.5 - $346.47 $162,517 - $242,182
699 New
699 $242,000
Q1 2021

May 06, 2021

SELL
$257.29 - $307.53 $261,149 - $312,142
-1,015 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$261.16 - $301.66 $170,015 - $196,380
-651 Reduced 39.08%
1,015 $288,000
Q3 2020

Nov 03, 2020

BUY
$224.99 - $288.02 $47,247 - $60,484
210 Added 14.42%
1,666 $458,000
Q2 2020

Jul 31, 2020

BUY
$149.8 - $227.17 $218,108 - $330,759
1,456 New
1,456 $331,000
Q4 2019

Feb 03, 2020

SELL
$137.6 - $151.21 $299,968 - $329,637
-2,180 Closed
0 $0
Q3 2019

Nov 01, 2019

BUY
$121.41 - $150.02 $264,673 - $327,043
2,180 New
2,180 $309,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.7B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.